Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-009205

General Counsel sold 52 shares at an average $9.50 ($494)

From the SEC's structured data for this filing

Trades in this filing

Miller Edward · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-23 Sale : show line 1 in the form −47 $9.45 $444 6,628 D
2025-01-23 Sale : show line 2 in the form −5 $9.94 $50 6,623 D
Open-market sales · 52 sh · avg $9.50 · $494
Loading xslF345X05/ownership.xml…